Report Detail
Global Preventable Vaccines Market Insights, Forecast to 2025
- RnM2390089 |
- 02 April, 2019 |
- Global |
- 142 Pages |
- QYResearch |
- Pharma & Healthcare
The global Preventable Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Preventable Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Preventable Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Preventable Vaccines in these regions.
This research report categorizes the global Preventable Vaccines market by top players/brands, region, type and end user. This report also studies the global Preventable Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Valeant Pharmaceuticals
Protein Sciences
Panacea Biotec
Market size by Product
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Market size by End User
Bacterial Diseases
Virus Diseases
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Preventable Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Preventable Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Preventable Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Preventable Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Preventable Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Preventable Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Preventable Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Preventable Vaccines Market Size Growth Rate by Product
- 1.4.2 Adult Preventable Vaccines
- 1.4.3 Pediatric Preventable Vaccines
- 1.5 Market by End User
- 1.5.1 Global Preventable Vaccines Market Size Growth Rate by End User
- 1.5.2 Bacterial Diseases
- 1.5.3 Virus Diseases
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Preventable Vaccines Market Size
- 2.1.1 Global Preventable Vaccines Revenue 2014-2025
- 2.1.2 Global Preventable Vaccines Sales 2014-2025
- 2.2 Preventable Vaccines Growth Rate by Regions
- 2.2.1 Global Preventable Vaccines Sales by Regions
- 2.2.2 Global Preventable Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Preventable Vaccines Sales by Manufacturers
- 3.1.1 Preventable Vaccines Sales by Manufacturers
- 3.1.2 Preventable Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Preventable Vaccines Revenue by Manufacturers
- 3.2.1 Preventable Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Preventable Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Preventable Vaccines Price by Manufacturers
- 3.4 Preventable Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Preventable Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Preventable Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Preventable Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Preventable Vaccines Sales by Product
- 4.2 Global Preventable Vaccines Revenue by Product
- 4.3 Preventable Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Preventable Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Preventable Vaccines by Countries
- 6.1.1 North America Preventable Vaccines Sales by Countries
- 6.1.2 North America Preventable Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Preventable Vaccines by Product
- 6.3 North America Preventable Vaccines by End User
7 Europe
- 7.1 Europe Preventable Vaccines by Countries
- 7.1.1 Europe Preventable Vaccines Sales by Countries
- 7.1.2 Europe Preventable Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Preventable Vaccines by Product
- 7.3 Europe Preventable Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Preventable Vaccines by Countries
- 8.1.1 Asia Pacific Preventable Vaccines Sales by Countries
- 8.1.2 Asia Pacific Preventable Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Preventable Vaccines by Product
- 8.3 Asia Pacific Preventable Vaccines by End User
9 Central & South America
- 9.1 Central & South America Preventable Vaccines by Countries
- 9.1.1 Central & South America Preventable Vaccines Sales by Countries
- 9.1.2 Central & South America Preventable Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Preventable Vaccines by Product
- 9.3 Central & South America Preventable Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Preventable Vaccines by Countries
- 10.1.1 Middle East and Africa Preventable Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Preventable Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Preventable Vaccines by Product
- 10.3 Middle East and Africa Preventable Vaccines by End User
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Preventable Vaccines Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis Preventable Vaccines Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Preventable Vaccines Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 Sanofi
- 11.5.1 Sanofi Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sanofi Preventable Vaccines Products Offered
- 11.5.5 Sanofi Recent Development
- 11.6 Takeda Pharmaceutical
- 11.6.1 Takeda Pharmaceutical Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
- 11.6.5 Takeda Pharmaceutical Recent Development
- 11.7 Abbott
- 11.7.1 Abbott Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Abbott Preventable Vaccines Products Offered
- 11.7.5 Abbott Recent Development
- 11.8 Roche
- 11.8.1 Roche Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Roche Preventable Vaccines Products Offered
- 11.8.5 Roche Recent Development
- 11.9 AstraZeneca
- 11.9.1 AstraZeneca Company Details
- 11.9.2 Company Business Overview
- 11.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 AstraZeneca Preventable Vaccines Products Offered
- 11.9.5 AstraZeneca Recent Development
- 11.10 Mitsubishi Tanabe Pharma
- 11.10.1 Mitsubishi Tanabe Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
- 11.10.5 Mitsubishi Tanabe Pharma Recent Development
- 11.11 Lupin
- 11.12 Serum Institute of India
- 11.13 LG Life Sciences
- 11.14 S K Chemicals
- 11.15 Shenzhen Kangtai Biological Products
- 11.16 Sinovac Biotech
- 11.17 Janssen Pharmaceuticals
- 11.18 Crucell
- 11.19 Bavarian Nordic
- 11.20 Baxter
- 11.21 Bharat Biotech
- 11.22 Dynavax
- 11.23 Valeant Pharmaceuticals
- 11.24 Protein Sciences
- 11.25 Panacea Biotec
12 Future Forecast
- 12.1 Preventable Vaccines Market Forecast by Regions
- 12.1.1 Global Preventable Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Preventable Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Preventable Vaccines Market Forecast by Product
- 12.2.1 Global Preventable Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Preventable Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Preventable Vaccines Market Forecast by End User
- 12.4 North America Preventable Vaccines Forecast
- 12.5 Europe Preventable Vaccines Forecast
- 12.6 Asia Pacific Preventable Vaccines Forecast
- 12.7 Central & South America Preventable Vaccines Forecast
- 12.8 Middle East and Africa Preventable Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Preventable Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Preventable Vaccines . Industry analysis & Market Report on Preventable Vaccines is a syndicated market report, published as Global Preventable Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Preventable Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
